Please login to the form below

Not currently logged in
Email:
Password:

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG).

Provided by Guidelines, it also features: NICE clinical guidelines, NICE quality standards, NICE evidence updates, NICE evidence summaries, independent professional body guidelines and (Scottish Intercollegiate Guidelines Network (SIGN) guidance.

Liraglutide for weight management

June 2017: NICE Evidence summary: new medicines

Air pollution: outdoor air quality and health

June 2017: NICE Public Health Guidance

British Association of Dermatologists' guidelines for biologic interventions for psoriasis (update)

July 2017: Independent professional body guideline

Psoriasis (Primary Care Dermatology Society)

July 2017: Independent professional body guideline

Bisphosphonates for adjuvant use in early breast cancer

July 2017: NICE Evidence summary: unlicensed/off-label medicines

Cardiac rehabilitation (update)

July 2017: SIGN guidance

Chronic kidney disease (QS update)

July 2017: NICE Quality Standard

Low back pain

July 2017: NICE Quality Standard

CVD prevention (update)

July 2017: SIGN guidance

Advanced Breast Cancer (standing committee update)

August 2017: NICE Clinical Guideline

Visit the Guidelines website

NICE backs Roche's Gazyvaro for lymphoma for Cancer Drugs Fund

NICE backs Roche's Gazyvaro for lymphoma for Cancer Drugs Fund 26 Jul 2017

Treatment will be used in conjunction with chemotherapy

NICE backs Teva's Cinqaero for severe asthma

NICE backs Teva's Cinqaero for severe asthma 21 Jul 2017

Ruling will allow it to compete with GSK's rival IL-5 inhibitor Nucala

UK pharma launches legal challenge to NICE plans

UK pharma launches legal challenge to NICE plans 13 Jul 2017

Applies for judicial review of budget impact test

NICE gives green light to Ipsen's Cabometyx

NICE gives green light to Ipsen's Cabometyx 12 Jul 2017

Backs the medicine’s use for patients with advanced kidney cancer

NICE broadens access to Alexion's rare disease drug Strensiq

NICE broadens access to Alexion's rare disease drug Strensiq 5 Jul 2017

New deal offers NHS England a discount for the drug

More news from PMLiVE on NICE, the SMC and the AWMSG

MGP’s Guidelines brand is trusted by over 58,000 healthcare professionals for concise clinical summaries of major primary and shared care guidelines in the UK. Through Guidelines, Guidelines for Nurses and Guidelines in Practice, MGP connect pharmaceutical and medical device companies to an engaged audience of GPs, GP commissioners and payers, nurses and allied healthcare professionals.

To discuss how we can support your guidance or implementation needs please contact marketing@mgp.co.uk

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Infographics